Physician profile
Scott H Daniel
NPI 1194757856
$3,919.49
in general payments reported to CMS, 2019-2025
33 companies · $857 in 2025
The $857 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $310 · 2021: $529 · 2022: $911 · 2023: $444 · 2024: $591 · 2025: $857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,891.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $345.33 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Myovant Sciences INC. | $328.28 | 2021-2022 | |
| Astellas Pharma US INC | $310.85 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $281.01 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $267.86 | 2022-2025 | |
| Organon LLC | $201.16 | 2021-2025 | Nexplanon |
| Avion Pharmaceuticals | $199.03 | 2019-2022 | |
| Novo Nordisk INC | $197.11 | 2020-2025 | Wegovy |
| Sage Therapeutics, LLC | $185.25 | 2025 | Zurzuvae |
| Pfizer INC. | $155.09 | 2020-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $148.63 | 2019-2022 | |
| Hologic Sales and Service, LLC | $124.41 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Mylan Pharmaceuticals INC. | $107.51 | 2021-2022 | |
| Daiichi Sankyo INC. | $90.38 | 2021-2023 | Injectafer |
| Scynexis, INC. | $82.14 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $79.58 | 2023-2025 | Eitan Medical, Vivify Health Care Team Portal 001, Vivify Health Care Team Portal |
| Exeltis, USA INC. | $79.12 | 2021-2024 | Slynd |
| Therapeuticsmd, INC. | $69.30 | 2019-2022 | |
| Coopersurgical, INC. | $65.32 | 2025 | Sos |
| Millicent US INC | $64.12 | 2025 | Intrarosa, Femlyv, Femring |
| Conmed Corporation | $60.29 | 2024 | Airseal |
| Exact Sciences Corporation | $57.78 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $57.44 | 2019-2024 | Gardasil 9, Gardasil |
| Supernus Pharmaceuticals, INC. | $53.65 | 2025 | Qelbree |
| Bayer Healthcare Pharmaceuticals INC. | $47.82 | 2024-2025 | |
| Amag Pharmaceuticals, INC. | $46.82 | 2019-2020 | |
| Shield Therapeutics INC | $46.26 | 2024 | |
| Agile Therapeutics, INC. | $44.52 | 2022 | |
| Aspira Women'S Health INC | $44.22 | 2020-2021 | |
| Axsome Therapeutics, INC. | $38.10 | 2025 | Auvelity |
| Evofem Biosciences, INC. | $15.29 | 2021 | |
| Amgen INC. | $13.18 | 2019 | |
| Endo Pharmaceuticals INC. | $12.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Daniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.